Medicinal cannabis is an herbal medicine that is used for many different medical conditions. The plant contains molecules known as cannabinoids that interact with the body's natural pathways and relieve the symptoms of several conditions. Some of these substances are pharmaceutical cannabis products that have been approved by the Therapeutic Goods Administration. These products include nabiximols (Sativex(r)) and synthetic cannabinoids (DRONABINOL(r)).
Although there are some pros and cons of medicinal cannabis, the public has generally accepted its medical value when used under the supervision of a health care provider. However, the implications of using cannabis in an acute care setting are complicated. Because of its Schedule I classification, hospitals are often hesitant to allow patients to use it on campus, for fear that the federal government may step in. However, many patients have reported positive results with the use of cannabis in hospitals. The Global Medicinal Cannabis Market is estimated at US$ 10,180.17 million in 2022 and is expected to witness a CAGR of 24.4% over the forecast period (2022 – 2030). Medicinal cannabis is available as oils, pills, and dried flower products. These products contain both THC and CBD and are used to treat a number of conditions. CBD-only products are popular with patients who suffer from anxiety and epilepsy. Further research into cannabis is ongoing in Australia and other countries. There are currently more than 100 products containing cannabis, and more are being developed all the time. In addition to these, there are several other forms of the plant. Scientific research into the medicinal use of cannabis has been progressing quickly. However, it must be understood that the lack of adequate blinding in studies involving cannabis has its drawbacks. Although cannabis is still illegal in some countries, there is some evidence that it may alleviate symptoms of many maladies, including pain, anxiety, and spasticity in multiple sclerosis. In addition, the National Academies of Science, Engineering, and Medicine recently concluded that cannabis and its cannabinoids have a significant positive impact on a number of ailments, including chronic pain in adults. Medicinal cannabis has been used to treat a variety of conditions, including nausea, pain, and inflammation. One observational study suggests that cannabis is effective for treating gastrointestinal symptoms in cancer patients. Other reports indicate that it may help patients with inflammatory bowel disease. However, the quality of the available evidence is low to moderate. The cannabis products are available over the counter in many health food stores and pharmacies. The products are not yet evaluated by the TGA for safety, effectiveness, or quality. However, there are a few clinical pathways for doctors to access the products. Despite the recent "liberalization" of the use of medical cannabis, its potential is still unexplored. Although the United Nations Single Convention on Narcotic Drugs recommends that marijuana use be illegal, recent research suggests that cannabis has neuroprotective, anxiolytic, antioxidant, anti-inflammatory, and anti-psychotic effects. Despite this, further research and evaluation are needed to determine if the drug is safe and has positive health impacts. Medical marijuana has a long history in Australia, but it is still a controversial plant that is not widely accepted. Its legality is still a controversial topic, and legislation governing its use is evolving quickly.
0 Comments
Leave a Reply. |
|